R-59-022 – 50 mg

Brand:
Cayman
CAS:
93076-89-2
Storage:
-20
UN-No:
Non-Hazardous - /

Diacylglycerol (DAG) kinases (DGKs) phosphorylate DAG to give phosphatidic acid (PA), reducing signaling through DAG and increasing signaling through PA.{7274} R-59-022 is an inhibitor of DGK (IC50 = 2.8 µM).{27715} This results in increased DAG-dependent PKC activity and potentiates aggregation of thrombin-stimulated platelets.{27715,27713} R-59-022 also blocks vascular contraction induced by the thromboxane analog U-46619 (Item No. 16450).{27712} At 10 µM, R-59-022 induces apoptosis in glioblastoma cells without being toxic to non-cancerous cells.{27710} It inhibits DGK-θ in vitro at concentrations below 1 µM and blocks DGK-θ activity in vivo.{27714} R-59-022 also inhibits A. thaliana DGK2 (IC50 = 50 µM) and suppresses root growth but does not affect DGK7 at 50 µM.{27711}  

 

Out of stock

SKU: - Category:

Description

An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC activity; blocks vascular contraction induced by U-46619 (Item No. 16450); induces apoptosis in glioblastoma cells without being toxic to non-cancerous cells; inhibits A. thaliana DGK2 (IC50 = 50 µM) and suppresses root growth but does not affect DGK7 at 50 µM


Formal name: 6-[2-[4-[(4-fluorophenyl)phenylmethylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one

Synonyms:  Diacylglycerol Kinase Inhibitor I

Molecular weight: 459.6

CAS: 93076-89-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|Other Lipid Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling||Research Area|Plant Biology